At the news
? NEUTRALIMPACT 3/10 8-K filed Mar 11, 2026 at 17:28 ET
Analysis based on filing metadata only, document content was unavailable. The filing is an 8-K with Item 5.02 disclosed, indicating a departure or appointment of directors or officers at Biogen Inc. (BIIB), but no details are available to assess the nature, participants, or implications of the change.
- Filing type is 8-K, indicating a material event.
- Item 5.02 reported: Departure or appointment of directors or officers.
- No document content available to determine who was involved, whether it was a resignation, retirement, or termination, or if a replacement was named.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access